TrialGynecologic oncology2019

Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218.

K N Slaughter Wade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.